PPIX Issues Director/PDMR Shareholding Notice
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
May 24, 2019
("ProPhotonix" or the "Company")
Director / PDMR Shareholding
ProPhotonix Limited (London Stock Exchange - AIM: PPIX, OTC: STKR), a high technology designer and manufacturer of LED illumination systems was notified on May 23, 2019 that Tim Losik, the Company's President and CEO, purchased 2,000,000 common shares of $0.001 in the Company ("Common Shares") on May 23, 2019, at a price of $0.0349 (£0.0274) per share. Following this purchase his beneficial holding amounts to 14,588,137 Common Shares representing 15.66 per cent of Common Shares in issue.
Tim Losik, President and CEO
Tel: +1 603 893 8778
Cantor Fitzgerald Europe
(Nominated Adviser and Broker)
Tel: +44 (0)207 894 7000
ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
CEO and President
Initial notification /Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Common shares of US$0.001 each
Nature of the transaction
Price(s) and volume(s)
- Aggregated volume
Date of the transaction
23 May 2019
Place of the transaction
LONDON STOCK EXCHANGE (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.